Terms ending in 2042
Every in-force patent on Givaudan S.A.'s record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,522,786 | Improvements in or Relating to Organic Compounds In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 12,779,079 | System and Method for Creating Digitized Aroma In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 12,336,820 | Methods of Preparing/Optimizing Perfume Compositions In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 12,539,268 | Cosmetic Composition In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 12,480,101 | Modified Host Cells for High Efficiency Production of Vanillin In force · High confidence | Amyris, Inc. | In force | High confidence | |
| US 12,351,546 | Method of Mitigating Conversion of Volatile Terpene Species In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 12,507,708 | Method of Extraction of Naural Caffeine from a Caffeine Containing Biological Material In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 12,496,566 | Process In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 12,378,214 | 12-Oxaspiro[5,5]UNDEC-8-ENE Useful in Fragrance Compositions In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 12,680,121 | Hyaluronic Acid-Producing Recombinant Cells In force · High confidence | Givaudan S.A. | In force | High confidence | |
| 9 more term ends in 2042 · Pro | |||||
10 of 19 patents shown. Soonest term end first, then patent number.
Pro members see all 19.
18 of these are in force and held by Givaudan S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.